HIF Activation Causes Synthetic Lethality Between the VHL Tumor Suppressor and the EZH1 Histone Methyltransferase

Science Translational Medicine - United States
doi 10.1126/scitranslmed.aal5272
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

The Positive Regulation of P53 by the Tumor Suppressor VHL

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2006English

VHL Deletion in Renal Epithelia Causes HIF-1α-dependent, HIF-2α-independent Angiogenesis and Constitutive Diuresis

Oncotarget
Oncology
2016English

Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation

Science
MultidisciplinaryPhilosophy of ScienceHistory
2012English

The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls

2012English

HIF-1α and EPAS Ubiquitination Mediated by the VHL Tumour Suppressor Involves Flexibility in the Ubiquitination Mechanism, Similar to Other RING E3 Ligases

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Cancer-Specific Synthetic Lethality Between ATR and CHK1 Kinase Activities

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

HCS Strategy Targeting Dysregulation of the VHL/HIF Pathway for Drug Discovery

Advances in Bioscience and Biotechnology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy